We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$867B
AUM Growth
-$1.1B
Cap. Flow
-$19.4B
Cap. Flow %
-2.24%
Top 10 Hldgs %
35.42%
Holding
3,110
New
92
Increased
1,805
Reduced
946
Closed
96

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$2.81B
2
BA icon
Boeing
BA
+$1.68B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.33B
4
APH icon
Amphenol
APH
+$1.11B
5
CME icon
CME Group
CME
+$902M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.65B
2
AMD icon
Advanced Micro Devices
AMD
+$2.51B
3
UNH icon
UnitedHealth
UNH
+$2.06B
4
UBER icon
Uber
UBER
+$1.84B
5
ADBE icon
Adobe
ADBE
+$1.44B

Sector Composition

Rank Sector Weight
1 Technology 33.21%
2 Healthcare 12.77%
3 Consumer Discretionary 11.71%
4 Financials 11.15%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBY icon
951
Best Buy
BBY
$17.5B
$23.9M ﹤0.01%
278,042
+1,316
+0.5% +$120K
LENZ
952
LENZ Therapeutics
LENZ
$145M
$23.8M ﹤0.01%
822,957
+374,326
+83% +$11.4M
QLYS icon
953
Qualys
QLYS
$6.47B
$23.7M ﹤0.01%
168,709
-76,695
-31% -$10.7M
J icon
954
Jacobs Solutions
J
$17B
$23.6M ﹤0.01%
178,668
+2,434
+1% +$335K
PFG icon
955
Principal Financial Group
PFG
$24.4B
$23.4M ﹤0.01%
302,579
-334
-0.1% -$28.1K
CINT icon
956
CI&T Inc
CINT
$465M
$23.4M ﹤0.01%
3,857,993
-115,974
-3% -$781K
SOFI icon
957
SoFi Technologies
SOFI
$23.8B
$23.4M ﹤0.01%
1,518,141
+41,248
+3% +$536K
GPC icon
958
Genuine Parts
GPC
$18.5B
$23.3M ﹤0.01%
199,953
+2,006
+1% +$250K
BJ icon
959
BJs Wholesale Club
BJ
$11.8B
$23.3M ﹤0.01%
260,884
-16,001
-6% -$1.45M
MAS icon
960
Masco
MAS
$14.7B
$23M ﹤0.01%
316,935
+4,420
+1% +$354K
PNR icon
961
Pentair
PNR
$10.5B
$23M ﹤0.01%
228,463
+706
+0.3% +$72.4K
PTCT icon
962
PTC Therapeutics
PTCT
$6.06B
$23M ﹤0.01%
509,204
-50,542
-9% -$2.16M
TNL icon
963
Travel + Leisure Co
TNL
$4.58B
$23M ﹤0.01%
455,491
+12,488
+3% +$634K
SLM icon
964
SLM Corp
SLM
$5.26B
$22.9M ﹤0.01%
831,008
+26,902
+3% +$665K
JBHT icon
965
JB Hunt Transport Services
JBHT
$25.9B
$22.8M ﹤0.01%
133,591
-12,060
-8% -$2.16M
IMVT icon
966
Immunovant
IMVT
$8.8B
$22.7M ﹤0.01%
916,250
-292,796
-24% -$8.31M
CNM icon
967
Core & Main
CNM
$8.62B
$22.6M ﹤0.01%
444,019
-202,247
-31% -$9.53M
ALHC icon
968
Alignment Healthcare
ALHC
$2.8B
$22.6M ﹤0.01%
2,005,777
+694,761
+53% +$8.12M
KOS icon
969
Kosmos Energy
KOS
$1.51B
$22.4M ﹤0.01%
6,548,777
-13,507,569
-67% -$51.4M
BCYC
970
Bicycle Therapeutics
BCYC
$284M
$22.2M ﹤0.01%
1,585,127
-136,913
-8% -$2.93M
ESI icon
971
Element Solutions
ESI
$9.51B
$22.2M ﹤0.01%
871,346
-525,372
-38% -$14.2M
EXPD icon
972
Expeditors International
EXPD
$24B
$22.1M ﹤0.01%
199,460
+341
+0.2% +$40.7K
SPNS
973
DELISTED
Sapiens International
SPNS
$21.9M ﹤0.01%
816,822
-6,186
-0.8% -$198K
IGMS
974
DELISTED
IGM Biosciences
IGMS
$21.8M ﹤0.01%
3,568,999
-445,260
-11% -$5.29M
HGV icon
975
Hilton Grand Vacations
HGV
$3.49B
$21.8M ﹤0.01%
559,414
+1,768
+0.3% +$69.7K

Similar funds

T. Rowe Price Associates's Q4 2024 Portfolio in Review

As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
  • T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
  • T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
  • T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
  • T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
  • T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
  • T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.

Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.